In Vivo Molecular Imaging (IMIV) lab, Inserm-CEA-CNRS-Paris 11 University
The French Alternative Energies and Atomic Energy Commission (CEA)
CEA is a French key player in research, development and innovation. It includes 10 research centres among which 51 research units employing 16.000 researchers, engineers, technologists and staff. It is the first French research centre in terms of patents filed (753 in 2015). CEA is very actively involved in the European Research organization, with 438 ongoing European projects in 2015. CEA created 187 start-ups since 1972 in the innovative technologies sector and has an annual budget of 4.1 billion euros.
IMIV is a research unit hosted by CEA and funded by CEA, Inserm, CNRS and Paris 11 University. This research unit is specialized in Positron Emission Tomography (PET) imaging and is located on the Service Hospitalier Frédéric Joliot (SHFJ) premises, which is a historical cradle of PET in France. IMIV currently includes 60 scientists and staff and is organized in 4 groups: the molecular probe group, the biomedical physics group, the experimental imaging group and the clinical investigation group, covering altogether all aspects of PET, from the production of original tracers up to first-in-man studies in volunteers and patients. IMIV benefits from the fully-equipped facility of the nuclear medicine department of SHFJ, including a tracer production unit, quality control labs, and 6 preclinical and clinical PET systems. This intimate link between basic and clinical research using PET imaging is a unique feature of the centre and allows for high standard translational research in PET.